The Union Conference will be held from 30th October till 2nd November in Hyderabad in India. The PAVIA consortium has organized the following consortium.
Sustainable models for strengthening pharmacovigilance of TB medicines and diagnostics: global and regional perspectives and country examples
The availability of new drugs and regimens for treatment of DR-TB with unclear safety profiles has fuelled attention to pharmacovigilance. Ensuring safe and effective use of these newer medicines is critically important to guarantee patient safety. This requires strengthening national pharmacovigilance systems, which in resource-limited countries are often weak and heavily dependent on external resources. Our objective is to: (1) Review strategies to ensure sustainability of ongoing pharmacovigilance efforts for anti-TB medicines (2) Share country examples of successful pharmacovigilance models from resource-limited settings (3) Identify priority issues for strengthening pharmacovigilance of anti-TB medicines and diagnostics in resourcelimited settings.The-Union-2019-World-Conference-Programme-1 (6 downloads)